At Biokinetica we understand that successful subjects’ recruitment largely depends on the interest of participating clinicians and places critical importance on patient selection and internal feasibility process.
Biokinetica possesses a highly qualified recruitment team, whose focus is to pursue successful recruitment of healthy volunteers and patients for clinical studies. The team utilizes large database of individuals as potential study subjects and employs a number of recruitment strategies using various forms of media. Through close cooperation with a network of referring physicians and clinics, Biokinetica has gained direct access to numerous patient populations of interest for clinical trials. Utilizing our relationships with external stakeholders as well as our internal subjects’ database, along with media/internet and advertisements in newspapers/handouts/flyers, we are able to meet predefined recruitment targets. Furthermore, in order to ensure the anticipated cohort size is met, sufficient number of subjects is screened to make provision for at least two reserve subjects per cohort.
The recruitment activities start shortly after study award notification. From study award notification through ethics committee approval, potential study participants are identified and contacted (selection process, not study-related).
This enables the recruitment staff to line up participants and have them ready for study specific informed consent and screening once all approvals are in place.
Our recruitment department located in the center of Warsaw has access to a population of > 5 million inhabitants. The database of >15,000 healthy volunteers and patients is continuously updated. Large database of healthy volunteers is essential to assure a fast recruitment of large groups. This is of particular importance for bioequivalence and biosimilar studies with large cohorts. Recruitment of specific patient population is assessed during the feasibility process and mainly based on database search, previous experience with specific populations, expertise and input from our network of referring physicians and clinics.
Specifically, Biokinetica has access to special patient populations by:
With these numerous cooperations we are able to successfully recruit patient groups from a variety of therapeutic areas. At Biokinetica we understand successful subjects’ recruitment rests largely on the interest of participating clinicians and places critical importance on the selection and internal feasibility processes.
From study award notification through ethics committee approval, potential study participants will be identified and contacted. This enables the unit to line up participants and have them ready for informed consent and screening once all approvals are in place.
We make every effort to ensure subject´s compliance in all our studies, and more importantly, in longer-term studies in the elderly population.
These include:
